Stockscreener 앱 받기
16.82
4.80%
0.775
전일 마감가:
$16.05
열려 있는:
$16.16
하루 거래량:
194.55K
Relative Volume:
0.79
시가총액:
$452.41M
수익:
$31.38M
순이익/손실:
$-6.69M
주가수익비율:
-64.71
EPS:
-0.26
순현금흐름:
$-1.84M
1주 성능:
+17.22%
1개월 성능:
+8.73%
6개월 성능:
-2.88%
1년 성능:
-0.94%
1일 변동 폭
$15.95
$17.00
1주일 범위
$14.49
$17.00
52주 변동 폭
$11.09
$23.00
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
명칭
Eton Pharmaceuticals Inc
전화
(847) 787-7361
주소
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
16.87 | 430.42M | 31.38M | -6.69M | -1.84M | -0.26 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.36 | 57.75B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.47 | 56.70B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.19 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.97 | 39.96B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
478.08 | 20.49B | 3.13B | 1.27B | 1.12B | 26.39 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-23 | 재확인 | H.C. Wainwright | Buy |
| 2025-01-10 | 개시 | B. Riley Securities | Buy |
| 2025-01-06 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-04 | 재개 | H.C. Wainwright | Buy |
| 2024-05-06 | 개시 | Craig Hallum | Buy |
| 2021-10-14 | 재개 | B. Riley Securities | Buy |
| 2021-01-04 | 재확인 | H.C. Wainwright | Buy |
| 2019-09-20 | 개시 | B. Riley FBR | Buy |
| 2019-06-10 | 개시 | H.C. Wainwright | Buy |
모두보기
Eton Pharmaceuticals Inc 주식(ETON)의 최신 뉴스
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Average Rating of "Hold" by Analysts - MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Average Rating of “Hold” by Analysts - Defense World
Analysts Are Bullish on These Healthcare Stocks: Eton Pharmaceuticals (ETON), HealthStream (HSTM) - The Globe and Mail
Eton Pharmaceuticals stock rises after licensing ultra-rare disease drug By Investing.com - Investing.com South Africa
Eton Pharmaceuticals stock rises after licensing ultra-rare disease drug - Investing.com India
Eton Pharmaceuticals Licenses US Marketing Rights to Ultra-Rare Disease Product - marketscreener.com
Eton Pharmaceuticals licenses ultra-rare disease treatment candidate - Investing.com
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate - The Manila Times
Eton Pharmaceuticals Licenses U.S. Marketing Rights for Ultra-Rare Disease Product Candidate, Anticipates FDA Approval by Mid-2026 - Quiver Quantitative
Aug Drivers: What drives Eton Pharmaceuticals Incs stock priceJuly 2025 Macro Moves & Real-Time Volume Analysis - baoquankhu1.vn
Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Unraveling the 96.72% Potential Upside for Investors - DirectorsTalk Interviews
Breakout Zone: Is Eton Pharmaceuticals Inc a defensive stockQuarterly Growth Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Eton Pharmaceuticals, Inc. (ETON) Investor Outlook: Unpacking The 96% Upside Potential - DirectorsTalk Interviews
Eton Pharmaceuticals: An Undervalued Small Cap With High Growth (NASDAQ:ETON) - Seeking Alpha
Geopolitics Watch: Can Eton Pharmaceuticals Inc maintain sales growthWatch List & Low Risk High Reward Ideas - baoquankhu1.vn
Insider Favorites: 3 Growth Stocks With Strong Ownership - simplywall.st
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
(ETON) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Exploring A Potential 94.68% Upside - DirectorsTalk Interviews
US Market Wrap: Can Eton Pharmaceuticals Inc maintain sales growthJuly 2025 Weekly Recap & Daily Stock Trend Reports - baoquankhu1.vn
Death Cross: Why Eton Pharmaceuticals Inc stock remains a top recommendationJuly 2025 Review & Real-Time Volume Trigger Notifications - Bộ Nội Vụ
Layoff Watch: Why is Eton Pharmaceuticals Inc stock going down2025 Support & Resistance & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Potential Upside of Over 81% in the Rare Disease Sector - DirectorsTalk Interviews
Can Eton Pharmaceuticals Inc. stock attract ESG capital inflowsJuly 2025 Retail & Weekly High Momentum Picks - Улправда
Why Eton Pharmaceuticals Inc. stock could rally in 20252026 world cup usa national team group stage playmakers transition play group prediction analysis - Улправда
How (ETON) Movements Inform Risk Allocation Models - Stock Traders Daily
Eton Pharmaceuticals (NASDAQ:ETON) Upgraded at Zacks Research - Defense World
Dental EconomicsEton Pharmaceuticals, Inc.Common Stock (Nasdaq:ETON) Stock Quote - FinancialContent
FDA extends target action date for Eton's ET-400 - MSN
Those who invested in Eton Pharmaceuticals (NASDAQ:ETON) three years ago are up 483% - Yahoo Finance
B. Riley Securities Initiates Coverage of Eton Pharmaceuticals (ETON) with Buy Recommendation - MSN
Understanding Momentum Shifts in (ETON) - Stock Traders Daily
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Is Eton Pharmaceuticals Inc. stock positioned for long term growth2025 Key Lessons & Growth Oriented Trading Recommendations - Улправда
What makes Eton Pharmaceuticals Inc. stock attractive to growth fundsWeekly Stock Report & Weekly High Conviction Ideas - Улправда
Eton Pharmaceuticals, Inc.(NasdaqGM: ETON) added to NASDAQ Biotechnology Index - marketscreener.com
Stock Market Recap: Why Eton Pharmaceuticals Inc. stock could rally in 2025July 2025 Institutional & Reliable Price Action Trade Plans - moha.gov.vn
Will Eton Pharmaceuticals Inc. stock beat EPS estimatesEarnings Beat & Verified Chart Pattern Signals - Улправда
Published on: 2025-12-20 13:06:24 - Улправда
Why Eton Pharmaceuticals Inc. stock could be next big winnerWeekly Trade Summary & Safe Entry Zone Identification - Улправда
Will Eton Pharmaceuticals Inc. stock maintain momentum in 2025Portfolio Gains Report & Free Weekly Watchlist of Top Performers - Bölüm Sonu Canavarı
Can Eton Pharmaceuticals Inc. stock continue upward trendProfit Target & Fast Momentum Stock Entry Tips - DonanımHaber
How Eton Pharmaceuticals Inc. stock trades before earningsJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - DonanımHaber
Published on: 2025-12-19 10:25:25 - Улправда
AI Stocks: Why Eton Pharmaceuticals Inc. stock could be next big winnerJuly 2025 Chart Watch & Consistent Return Investment Signals - Улправда
Aug Big Picture: Why Eton Pharmaceuticals Inc. stock could rally in 2025Profit Target & Stepwise Trade Signal Guides - Улправда
Analysts’ Top Healthcare Picks: Foghorn Therapeutics (FHTX), Eton Pharmaceuticals (ETON) - The Globe and Mail
Highlighting December 2025's Growth Leaders With Insider Ownership - simplywall.st
(ETON) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Eton Pharmaceuticals (NASDAQ:ETON) Downgraded by Wall Street Zen to Hold - Defense World
Eton Pharmaceuticals, Inc. (ETON) CCO records 85-share tax withholding transaction - Stock Titan
Eton Pharmaceuticals Inc (ETON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.56%
10.18%
자본화:
|
볼륨(24시간):